Literature DB >> 10751798

Interobserver Reproducibility and Biological Variability of the Surgicutt II Bleeding Time.

.   

Abstract

The bleeding time is a readily and easily performed clinical test with immediate results, but there is a degree of subjectivity in its performance and interpretation. We performed a study on 27 volunteers designed to determine the normal range, interobserver reproducibility, and biological variability of the test. Bleeding times in these normal subjects ranged from as low as 129 seconds to as high as 803 seconds. The interobserver variability was 106 seconds (2 standard deviations of the mean of the differences of paired results of repeated measurements), and the coefficient of variation was 18%. For bleeding times taken on the same subjects 6 weeks apart, when the same nurse performed the test at both visits, the difference was 150 seconds (2 standard deviations of the mean of the differences of paired samples) and the coefficient of variation was 27%, and they were essentially the same if a different nurse performed the tests at each visit. There is a wide range in the bleeding times among subjects. However, within individuals there is little biological variability, and most of the difference over time is due to interobserver variability. This suggests that changes in bleeding time are clinically useful in predicting platelet responsiveness in individual patients.

Entities:  

Year:  1998        PMID: 10751798     DOI: 10.1023/A:1008861924107

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  3 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group.

Authors:  M M Bernardi; R M Califf; N Kleiman; S G Ellis; E J Topol
Journal:  Am J Cardiol       Date:  1993-11-15       Impact factor: 2.778

3.  Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically.

Authors:  M R Buchanan; S J Brister
Journal:  Can J Cardiol       Date:  1995-03       Impact factor: 5.223

  3 in total
  2 in total

1.  Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.

Authors:  Erik I Tucker; Ulla M Marzec; Michelle A Berny; Sawan Hurst; Stuart Bunting; Owen J T McCarty; András Gruber; Stephen R Hanson
Journal:  Sci Transl Med       Date:  2010-06-23       Impact factor: 17.956

Review 2.  Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.

Authors:  Karen S Brown; Hamim Zahir; Michael A Grosso; Hans J Lanz; Michele F Mercuri; Jerrold H Levy
Journal:  Crit Care       Date:  2016-09-23       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.